Psychological Mobile App for Patients With AML

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
AMLAcute Myeloid Leukemia
Interventions
BEHAVIORAL

DREAMLAND

"DREAMLAND is self-administered psychological app for patients with AML that includes four modules, focused on:~1. Supportive psychotherapy strategies to help patients deal with the initial shock of diagnosis, cope with the loss of independence and abrupt life disruptions, and provide validation and reassurance.~2. Psychoeducation to manage expectations and enhance preparedness for extended hospitalization and mobilize social support.~3. Psychosocial skill-building to promote effective coping strategies and facilitate acceptance while living with uncertainty.~4. Self-care to promote positive health behaviors and enhance patients´ sense of control especially as they transition from the hospital to outpatient care.~Each module takes 20 minutes to complete. DREAMLAND also includes three optional models that also take 15 minutes to complete.~Other names BNT200"

BEHAVIORAL

CERENA

"CERENA is a self-administered physical health app that includes 4 modules focused, focused on:~1. Education about general wellness.~2. Nutrition.~3. Exercise.~4. Cancer prevention.~Each module takes 20 minutes to complete. CERENA also includes three optional modules that also take 15 minutes to complete."

Trial Locations (3)

27710

Duke University, Durham

98109

Fred Hutchinson Cancer Research Center, Seattle

02115

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Blue Note Therapeutics

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT05501171 - Psychological Mobile App for Patients With AML | Biotech Hunter | Biotech Hunter